CN Patent

CN107998074A — 普瑞巴林口服溶液及其制备方法

Assigned to GUANGZHOU DAGUANG PHARMACEUTICAL CO Ltd · Expires 2018-05-08 · 8y expired

What this patent protects

本发明涉及一种普瑞巴林口服溶液及其制备方法，本发明所述口服液体制剂含有普瑞巴林、防腐剂、缓冲剂和矫味剂等组分，本发明采用水作为溶剂，通过各组分的定量配比及协同作用，使本发明口服液体制剂具有好的稳定性，同时口味得到好的改善，患者的生存质量及用药顺应性也得到有效的改善，且口服液体制剂生物利用度明显高于固体制剂，更适于老人或儿童服用。

USPTO Abstract

本发明涉及一种普瑞巴林口服溶液及其制备方法，本发明所述口服液体制剂含有普瑞巴林、防腐剂、缓冲剂和矫味剂等组分，本发明采用水作为溶剂，通过各组分的定量配比及协同作用，使本发明口服液体制剂具有好的稳定性，同时口味得到好的改善，患者的生存质量及用药顺应性也得到有效的改善，且口服液体制剂生物利用度明显高于固体制剂，更适于老人或儿童服用。

Drugs covered by this patent

Patent Metadata

Patent number: CN107998074A
Jurisdiction: CN
Classification: —
Expires: 2018-05-08
Drug substance claim: No
Drug product claim: No
Assignee: GUANGZHOU DAGUANG PHARMACEUTICAL CO Ltd
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.